|
 |
| |
|
¹ÙÀÌÅ丰Á¤10/20 Vytorin Tab. 10/20
|
Àü¹®ÀǾàǰ | ±Þ¿©
|
|
|
¼öÀÔÀǾàǰ
|
| |
 |
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
|
| ¹é»ö³»Áö ¹Ì¹é»öÀÇ ÇÑ ¸é¿¡ 312ÀÌ »õ°ÜÁø ¾ç¸éÀÌ º¼·ÏÇÑ Ä¸½¶¸ð¾çÀÇ Á¤Á¦
|
|
|
|
|
|
Á¦Á¶È¸»ç |
Çѱ¹¿À°¡³í(ÁÖ)
|
ÆÇ¸Åȸ»ç |
Çѱ¹¿À°¡³í(ÁÖ)
|
Çã°¡Á¤º¸ |
Á¤»ó
(2005.01.31)
|
BIT ¾àÈ¿ºÐ·ù |
°íÁöÇ÷Áõ Ä¡·áÁ¦ (Antilipidemic Agents)
|
º¹ÁöºÎºÐ·ù |
218[µ¿¸Æ°æÈ¿ëÁ¦ ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
073100070 Àú°¡¾à ´ëü Àμ¾Æ¼ºê Áö±Þ ´ë»ó \1,089 ¿ø/1Á¤(2024.07.01)(ÇöÀç¾à°¡)\1,091 ¿ø/1Á¤(2022.01.01) (º¯°æÀü¾à°¡)
|
|
|
ATCÄÚµå |
simvastatin and ezetimibe / C10BA02 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]

|
÷°¡Á¦ |
±¸¿¬»ê,
¹Ì°áÁ¤¼¿·ê·Î¿À½º,
ºÎÄ¥È÷µå·Ï½Ã¾Æ´Ï¼Ö,
½ºÅ׾Ƹ°»ê¸¶±×³×½·,
À¯´ç,
Å©·Î½ºÄ«¸á·Î¿À½º³ªÆ®·ý,
ÇÁ·ÎÇʰ¥·¹ÀÌÆ®,
ÇÏÀÌÇÁ·Î¸á·Î¿À½º
|
|
|
|
|
 |
|
|
|
|
|
| Ç× ¸ñ |
³» ¿ë |
|
ºÎÀÛ¿ëºóµµ ¹× ´ëó¹ý |
[À¯·á] |
|
|
| |
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2025-08-30 |
|
|
|
|
| |
|
|
|